[go: up one dir, main page]

WO2010134025A3 - Oral compositions of celecoxib - Google Patents

Oral compositions of celecoxib Download PDF

Info

Publication number
WO2010134025A3
WO2010134025A3 PCT/IB2010/052210 IB2010052210W WO2010134025A3 WO 2010134025 A3 WO2010134025 A3 WO 2010134025A3 IB 2010052210 W IB2010052210 W IB 2010052210W WO 2010134025 A3 WO2010134025 A3 WO 2010134025A3
Authority
WO
WIPO (PCT)
Prior art keywords
celecoxib
oral compositions
compositions
relates
present
Prior art date
Application number
PCT/IB2010/052210
Other languages
French (fr)
Other versions
WO2010134025A2 (en
Inventor
Ravindra Agarwal
Piyush Kansagra
Rajeev Raghuvanshi
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Priority to AU2010250800A priority Critical patent/AU2010250800A1/en
Priority to CA2762388A priority patent/CA2762388A1/en
Priority to EP10722778.7A priority patent/EP2432459A2/en
Publication of WO2010134025A2 publication Critical patent/WO2010134025A2/en
Publication of WO2010134025A3 publication Critical patent/WO2010134025A3/en
Priority to ZA2011/08413A priority patent/ZA201108413B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to disintegrant free oral compositions comprising celecoxib. It further relates to processes for preparing such compositions. It also relates to method of treating cyclooxygenase-2 mediated disorders using compositions of the present invention.
PCT/IB2010/052210 2009-05-20 2010-05-18 Oral compositions of celecoxib WO2010134025A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2010250800A AU2010250800A1 (en) 2009-05-20 2010-05-18 Oral compositions of celecoxib
CA2762388A CA2762388A1 (en) 2009-05-20 2010-05-18 Oral compositions of celecoxib
EP10722778.7A EP2432459A2 (en) 2009-05-20 2010-05-18 Oral compositions of celecoxib
ZA2011/08413A ZA201108413B (en) 2009-05-20 2011-11-16 Oral compositions of celecoxib

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1036/DEL/2009 2009-05-20
IN1036DE2009 2009-05-20

Publications (2)

Publication Number Publication Date
WO2010134025A2 WO2010134025A2 (en) 2010-11-25
WO2010134025A3 true WO2010134025A3 (en) 2011-11-10

Family

ID=42536343

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2010/052210 WO2010134025A2 (en) 2009-05-20 2010-05-18 Oral compositions of celecoxib

Country Status (5)

Country Link
EP (1) EP2432459A2 (en)
AU (1) AU2010250800A1 (en)
CA (1) CA2762388A1 (en)
WO (1) WO2010134025A2 (en)
ZA (1) ZA201108413B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2761212A1 (en) * 2011-12-07 2013-06-07 Pharmascience Inc. Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of it manufacturing
WO2015044961A2 (en) * 2013-09-30 2015-04-02 Intas Pharmaceuticals Limited Pharmaceutical composition comprising capecitabine and cyclophosphamide
US10016447B2 (en) 2014-09-26 2018-07-10 Intas Pharmaceuticals Ltd. Pharmaceutical composition having improved content uniformity
US10350171B2 (en) 2017-07-06 2019-07-16 Dexcel Ltd. Celecoxib and amlodipine formulation and method of making the same
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1049467A1 (en) * 1998-11-30 2000-11-08 G.D. Searle & Co. Celecoxib compositions
WO2002005799A2 (en) * 2000-07-13 2002-01-24 Pharmacia Corporation Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
WO2009063367A1 (en) * 2007-11-15 2009-05-22 Pfizer Products Inc. Dosage forms comprising celecoxib providing both rapid and sustained pain relief

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1049467A1 (en) * 1998-11-30 2000-11-08 G.D. Searle & Co. Celecoxib compositions
WO2002005799A2 (en) * 2000-07-13 2002-01-24 Pharmacia Corporation Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
WO2009063367A1 (en) * 2007-11-15 2009-05-22 Pfizer Products Inc. Dosage forms comprising celecoxib providing both rapid and sustained pain relief

Also Published As

Publication number Publication date
AU2010250800A1 (en) 2012-01-12
WO2010134025A2 (en) 2010-11-25
ZA201108413B (en) 2012-09-26
EP2432459A2 (en) 2012-03-28
CA2762388A1 (en) 2010-11-25

Similar Documents

Publication Publication Date Title
WO2010134025A3 (en) Oral compositions of celecoxib
WO2010102980A8 (en) Process for preparing substituted 2-nitrobiphenyls
IN2014CN04907A (en)
WO2009139817A3 (en) Crystalline pharmaceutical and methods of preparation and use thereof
EP2273880A4 (en) Novel formulations for treatment of migraine
WO2009126688A3 (en) Novel compositions and methods for the treatment of immune related diseases
WO2011006143A3 (en) Fused imidazoles and compositions comprising them for the treatment of parasitic diseases, such as e.g. malaria
WO2011019986A3 (en) Processes for preparing pemetrexed
IN2012DN00971A (en)
WO2010049454A3 (en) Antimicrobial composition from copepods
IL209360A (en) Pharmaceutical compositions comprising pm00104 for the treatment of multiple myeloma
EP2490721A4 (en) Compositions, methods for treatment, and diagnoses of autoimmunity-related disorders and methods for making such compositions
WO2009053446A3 (en) Pregabalin intermediates and process for preparing them and pregabalin
WO2014068586A3 (en) Solid oral compositions of tolvaptan
WO2008075205A3 (en) Improved process for the preparation of voriconazole
WO2013076743A3 (en) Process for the purification of polyaminocarboxylates
MX339361B (en) Alternan derivatives.
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
EP2344468A4 (en) Process for the preparation of ramelteon
WO2010015656A3 (en) Alkoxypyrazoles and the process for their preparation
IL222400A (en) Process for the preparation of 3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic acid (9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)-amide which involves fulven or its 6-alkyl derivatives
WO2012063269A3 (en) Process for preparing iloperidone
MX339772B (en) Method and composition for reducing the color of sugar.
WO2011067236A3 (en) Raltegravir polymorphs
IN2012DN00289A (en)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10722778

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2762388

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2010722778

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010250800

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2010250800

Country of ref document: AU

Date of ref document: 20100518

Kind code of ref document: A